105 PHASE 2, MULTICENTER, RANDOMIZED STUDY OF AST-120 (SPHERICAL CARBON ADSORBENT) VS. LACTULOSE IN THE TREATMENT OF LOW-GRADE HEPATIC ENCEPHALOPATHY (HE)

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Hepatology

• Publication date

  2009-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8278(09)60107-0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Hepatic encephalopathy: experimental drugs in development and therapeutic potential

  2024cites this paper
• The Value of Ammonia as a Biomarker in Patients with Cirrhosis

  2024cites this paper
• Prophylaxis of hepatic encephalopathy: current and future drug targets

  2024cites this paper
• Active Clinical Trials in Hepatic Encephalopathy: Something Old, Something New and Something Borrowed

  2023cites this paper
• Novel Drugs for the Management of Hepatic Encephalopathy: Still a Long Journey to Travel.

  2022cites this paper
• Hepatic Encephalopathy: Current and Emerging Treatment Modalities.

  2022cites this paper
• Novel Agents in the Management of Hepatic Encephalopathy: A Review

  2021cites this paper
• Ammonia Removal by Metabolic Scavengers for the Prevention and Treatment of Hepatic Encephalopathy in Cirrhosis

  2021influential citation
• Novel Therapies in Hepatic Encephalopathy.

  2020cites this paper
• Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.

  2019cites this paper
• Update on the Therapeutic Management of Hepatic Encephalopathy

  2018cites this paper
• Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.

  2016cites this paper
• Ammonia scavenging agents for people with cirrhosis and hepatic encephalopathy

  2016cites this paper
• Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia

  2016cites this paper
• Novel Ammonia-Lowering Agents for Hepatic Encephalopathy.

  2015cites this paper
• Recent insights into the pathogenesis of hepatic encephalopathy and

  2014cites this paper
• Recent insights into the pathogenesis of hepatic encephalopathy and treatments

  2014cites this paper
• Ammonia‐Lowering Strategies for the Treatment of Hepatic Encephalopathy

  2012cites this paper
• Management of overt hepatic encephalopathy.

  2012cites this paper
• AST‐120 (spherical carbon adsorbent) lowers ammonia levels and attenuates brain edema in bile duct–ligated rats

  2011cites this paper
• Current concepts in the pathophysiology and management of hepatic encephalopathy.

  2011cites this paper
• Tratamiento de la ascitis y la encefalopatía hepática

  2010influential citation
• Rifaximin for the treatment of hepatic encephalopathy

  2010cites this paper
• Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy

  2009cites this paper